Completed PHASE4 INTERVENTIONAL 2-arm NCT03036059

Twice Yearly Treatment for the Control of LF

Cluster Randomized Community-based Trial of Annual Versus Biannual Single-dose Ivermectin Plus Albendazole Against Wuchereria Bancrofti Infection in Human and Mosquito Populations

Sponsor: Ghana Health Services

Conditions Helminth Infection Lymphatic Filariasis

Interventions 400 μg/kg Ivermectin + 400 mg Albendazole

Updated 7 times since 2017 Last updated: Feb 25, 2020 Started: May 19, 2017 Primary completion: Dec 8, 2019 Completion: Dec 8, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03036059, this PHASE4 trial focuses on Helminth Infection and Lymphatic Filariasis and remains completed. Sponsored by Ghana Health Services, it has been updated 7 times since 2017, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Mar 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jun 2018 — Mar 2020 [monthly]

Recruiting PHASE4

▶ Show 2 earlier versions

Jun 2017 — Jun 2018 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Feb 2017 — Jun 2017 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ghana Health Services
Noguchi Memorial Institute for Medical Research

Data source: Noguchi Memorial Institute for Medical Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Legon-Accra, Ghana